These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9620030)

  • 1. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
    Goldstein NS; Mani A
    Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
    Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
    Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD; Duska LR; Rosenshein NB
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of cone margins and post-cone endocervical curettage with residual disease in subsequent hysterectomy.
    Husseinzadeh N; Shbaro I; Wesseler T
    Gynecol Oncol; 1989 May; 33(2):198-200. PubMed ID: 2703181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the mechanisms underlying the disparity between rate of residual endocervical adenocarcinoma in situ (AIS) in hysterectomy specimens and clinical failure rate following conservatively treated AIS.
    Goldstein NS
    Am J Clin Pathol; 2004 Oct; 122(4):540-5. PubMed ID: 15487451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
    Huang SS; Sui L; Chen LM; Zhang HW; Tao X
    Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
    [No Abstract]   [Full Text] [Related]  

  • 13. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy.
    Moore BC; Higgins RV; Laurent SL; Marroum MC; Bellitt P
    Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ; Hernandez E; Mudafort E; Miyazawa K
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
    Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
    Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative Treatment for Patients with Carcinoma in Situ-Positive Margins After a Loop Electroexcisional Procedure: Is It Safe?
    Chong GO; Lee YH; Lee YS; Cho YL; Park JY; Hong DG
    J Reprod Med; 2017; 62(1-2):37-44. PubMed ID: 29999280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.